Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

(2015) Masaru Kanekiyo et al.   CELL

Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA

(2015) Rosemary J Tierney et al.   VIROLOGY

Co-infections, inflammation and oncogenesis: Future directions for EBV research

(2014) A.B. Rickinson   SEMINARS IN CANCER BIOLOGY

Progress, prospects, and problems in Epstein-Barr virus vaccine development

(2014) Henry H Balfour   Current Opinion in Virology

CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response

(2013) R. J. M. Abbott et al.   JOURNAL OF IMMUNOLOGY

EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail

(2013) B. D. Griffin et al.   JOURNAL OF IMMUNOLOGY

The need and challenges for development of an Epstein-Barr virus vaccine

(2013) Jeffrey I. Cohen et al.   VACCINE

Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students

(2012) Henry H. Balfour et al.   JOURNAL OF INFECTIOUS DISEASES

RNAs in Epstein-Barr virions control early steps of infection

(2012) S. Jochum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination

(2012) Simon Jochum et al.   PLoS Pathogens

Human B cells on their route to latent infection – Early but transient expression of lytic genes of Epstein-Barr virus

(2011) Markus Kalla et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle Recognition

(2011) H. M. Long et al.   JOURNAL OF IMMUNOLOGY

Epstein-Barr Virus BamHI W Repeat Number Limits EBNA2/EBNA-LP Coexpression in Newly Infected B Cells and the Efficiency of B-Cell Transformation: a Rationale for the Multiple W Repeats in Wild-Type Virus Strains

(2011) R. J. Tierney et al.   JOURNAL OF VIROLOGY

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge

(2011) Junji Sashihara et al.   PLoS Pathogens

Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

(2010) Alberto Ascherio et al.   Journal of Neuroimmune Pharmacology

Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation

(2009) C. Smith et al.   BLOOD

Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition

(2009) J. M. Brooks et al.   JOURNAL OF IMMUNOLOGY

Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification

(2009) C. Shannon-Lowe et al.   JOURNAL OF VIROLOGY

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

(2009) Gemma L. Kelly et al.   PLoS Pathogens